Low molecular weight peptides with anti-thrombin and anti-urokinase activity isolated from human maternal and cord blood serum and amniotic fluid
- PMID: 989267
- DOI: 10.1007/BF00667676
Low molecular weight peptides with anti-thrombin and anti-urokinase activity isolated from human maternal and cord blood serum and amniotic fluid
Abstract
Peptides with antithrombin and anti-urokinase activity were isolated from maternal and cord blood serum and amniotic fluid from pregnant women at term. Chromatography data, fingerprinting and activity of peptide inhibitors revealed active peptides, which were similar to those recently isolated from human placenta. They are distinctly different from protein inhibitors previously isolated from human placenta.
Similar articles
-
[Protein and peptide fribrinolysis inhibitor in human amniotic fluid].Ginekol Pol. 1980 Feb;51(2):113-8. Ginekol Pol. 1980. PMID: 6989713 Polish. No abstract available.
-
Isolation of peptides with anti-urokinase activity from the human placenta.Thromb Haemost. 1980 Feb 29;42(5):1411-6. Thromb Haemost. 1980. PMID: 6768150
-
Lead and cadmium concentrations in maternal and umbilical cord blood, amniotic fluid, placenta, and amniotic membranes.Am J Obstet Gynecol. 1986 Nov;155(5):1086-9. doi: 10.1016/0002-9378(86)90356-x. Am J Obstet Gynecol. 1986. PMID: 3777054
-
Specific plasminogen activator inhibitor of placental type PAI 2 occurring in amniotic fluid and cord blood.J Lab Clin Med. 1987 Nov;110(5):602-5. J Lab Clin Med. 1987. PMID: 3499478
-
Coagulation and fibrinolysis in amniotic fluid: physiology and observations on amniotic fluid embolism, preterm fetal membrane rupture, and pre-eclampsia.Semin Thromb Hemost. 2011 Mar;37(2):165-74. doi: 10.1055/s-0030-1270345. Epub 2011 Mar 2. Semin Thromb Hemost. 2011. PMID: 21370219 Review.